Literature DB >> 24795111

Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management.

Kristen K Miller1, Loren Gorcey1, Beth N McLellan2.   

Abstract

Chemotherapy-induced hand-foot syndrome and nail changes are common complications of many classic chemotherapeutic agents and the newer molecular targeted therapies. They significantly impact patient quality of life, and frequently necessitate chemotherapy dose intensity modification or reduction. We aim to describe the epidemiology, pathogenesis, clinical presentation, and current evidence-based treatment options for these entities.
Copyright © 2014 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chemotherapy complications; chemotherapy nail complications; hand-foot skin reaction; hand-foot syndrome; molecular targeted therapy complications; palmoplantar erythrodysesthesia

Mesh：

Substances：

Year:  2014        PMID： 24795111     DOI： 10.1016/j.jaad.2014.03.019

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  40 in total

Review 1.  Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis.

Authors:  V R Belum; C Serna-Tamayo; S Wu; M E Lacouture
Journal:  Clin Exp Dermatol       Date:  2015-05-25       Impact factor: 3.470

Review 2.  Podiatric Adverse Events and Foot Care in Cancer Patients and Survivors Awareness, Education, and Literature Review.

Authors:  Mario E Lacouture; David J Kopsky; Raphael Lilker; Fiona Damstra; Mecheline H M van der Linden; Azael Freites-Martinez; Mischa P M Nagel
Journal:  J Am Podiatr Med Assoc       Date:  2018-11

Review 3.  Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib.

Authors:  Alessandro Granito; Sara Marinelli; Giulia Negrini; Saverio Menetti; Francesca Benevento; Luigi Bolondi
Journal:  Therap Adv Gastroenterol       Date:  2016-03       Impact factor: 4.409

Review 4.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

5.  Cytarabine and Doxorubicin-Induced Palmoplantar Erythrodysesthesia Syndrome: The Possible Role of Voriconazole Interaction.

Authors:  Maria Tavakoli-Ardakani; Shirin Haghighi; Shervin Shokouhi; Bahareh Abtahi-Naeini; Mohsen Meidani; Rezvan Hassanpour; Ali Saffaei
Journal:  Eurasian J Med       Date:  2019-10

6.  Palmar-plantar erythrodysesthesia associated with high-dose methotrexate: Case report.

Authors:  Priyanka Chauhan; Anshul Gupta; Sujeet Kumar; Arijit Bishnu; Soniya Nityanand
Journal:  Cancer Rep (Hoboken)       Date:  2020-08-07

Review 7.  [Cutaneous side effects of targeted cancer drugs].

Authors:  J Below; B Homey; P A Gerber
Journal:  Hautarzt       Date:  2017-01       Impact factor: 0.751

Review 8.  Cutaneous Complications of Targeted Melanoma Therapy.

Authors:  Emily de Golian; Bernice Y Kwong; Susan M Swetter; Silvina B Pugliese
Journal:  Curr Treat Options Oncol       Date:  2016-11

9.  Do you know this syndrome? Hand-foot syndrome.

Authors:  Cintia Santos Braghiroli; Rodrigo Ieiri; Juliana Polizel Ocanha; Rafael Bispo Paschoalini; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

10.  SNPs in the COX-2/PGES/EP signaling pathway are associated with risk of severe capecitabine-induced hand-foot syndrome.

Authors:  Xin Liao; Liu Huang; Qianqian Yu; Siyuan He; Qianxia Li; Chao Huang; Xianglin Yuan
Journal:  Cancer Chemother Pharmacol       Date:  2020-03-19       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.